Qigong Therapy for Individuals With Knee Osteoarthritis

Phase 2

Completed

• Conditions: Osteoarthritis

• Registration Number: NCT00104156
• Lead Sponsor: National Center for Complementary and Integrative Health (NCCIH)

Brief Summary

The purpose of this study is to evaluate the effectiveness of Qigong therapy, an ancient Chinese practice, for pain relief and symptom improvement in people with knee osteoarthritis (OA).

Study hypotheses: 1) Qigong therapy will result in greater reduction of pain and greater symptom improvement than sham treatment. 2) Individuals with a history of complementary and alternative medicine (CAM) use will be more likely to experience benefits of Qigong therapy than those without such experience.

Detailed Description

OA is the leading cause of disability in the United States. Standard treatment for OA is drug therapy; however, cost, side effects, and varying levels of effectiveness warrant the need for development of new treatments. Qigong therapy, which involves deep meditation, breathing exercises, and the harnessing of energy, may be an effective treatment for OA.

According to traditional Chinese medicine, Qi (Chi) is the "life force" that flows through the body and keeps people healthy and vital. In the practice of traditional Chinese medicine, arthritis is thought to be due to a blockage of the flow of Qi or a buildup of abnormal or damaging Qi. It is believed that releasing this buildup or breaking the blockage of Qi through Qigong therapy may relieve OA symptoms.

Participants will be randomly assigned to receive five sessions of either Qigong therapy or sham treatment over a period of 2 weeks. During Qigong therapy, a therapist will send his or her Qi to the arthritic knees through touch and meditation. Similar body work will be performed during the sham treatment, but no Qi will be harnessed. Self-report scales that measure pain, stiffness, anxiety, daily drug use, CAM use, and overall functioning will be used to assess participants. The assessments will occur at study start and at a 3-month follow-up visit.

Study Timeline

• Study Start: 2005-01
• Study First Submitted: 2005-02-23
• Study First Submitted QC: 2005-02-23
• Study First Posted: 2005-02-24
• Primary Completion: 2007-08
• Study Completion: 2007-08
• Status Verified: 2008-01
• Last Update Submitted: 2008-01-23
• Last Update Posted: 2008-01-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Diagnosis of osteoarthritis at least 6 months prior to study entry
• Able to understand English

Exclusion Criteria

• Inflammatory joint disease affecting leg movement
• Knee replacement surgery on the OA knee
• Depo-corticosteroid knee injections within 3 months prior to study entry
• Pain in hips or lower back affecting leg movement
• New arthritis drugs or other painkillers within 2 weeks prior to study entry
• Investigational drugs within 30 days prior to study entry
• Asthma requiring oral corticosteroids within 4 weeks prior to study entry

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Pain, stiffness, and physical function scale results

Secondary Outcome Measures

Name	Time	Method
Spielberger State-Trait Anxiety Scale (STAI) results
Daily dosage of drugs for pain relief
McGill Pain Questionnaire (MPQ-SF) results
Range of motion for knees
Time to walk 50 feet

Trial Locations

Locations (1)

University of Medicine and Dentistry, New Jersey-Robert Wood Johnson Medical School; 🇺🇸 Piscataway, New Jersey, United States